Acro Biomedical (ACBM) Cash & Equivalents Growth (1y) (2016 - 2025)
Acro Biomedical (ACBM) Cash & Equivalents Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 0.00% |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 760.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 760.92% |
| Sep 30, 2025 | 516.69% |
| Jun 30, 2025 | -97.19% |
| Mar 31, 2025 | 66.23% |
| Dec 31, 2024 | 26.60% |
| Sep 30, 2024 | -78.57% |
| Jun 30, 2024 | -65.45% |
| Mar 31, 2024 | -53.11% |
| Dec 31, 2023 | -93.57% |
| Sep 30, 2023 | -79.79% |
| Jun 30, 2023 | -77.86% |
| Mar 31, 2023 | -99.91% |
| Dec 31, 2022 | -93.86% |
| Sep 30, 2022 | -89.53% |
| Jun 30, 2022 | -94.38% |
| Mar 31, 2022 | 1,368.32% |
| Dec 31, 2021 | 425.56% |
| Sep 30, 2021 | 99,042.95% |
| Jun 30, 2021 | 56,460.10% |
| Mar 31, 2021 | 129.02% |